Logo-jcvtr

Submitted: 31 May 2025
Revision: 30 Nov 2025
Accepted: 10 Jan 2026
ePublished: 18 Aug 2026
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Cardiovasc Thorac Res. 2026;18(2): 93-102.
doi: 10.34172/jcvtr.33605
  Abstract View: 1

Review Article

Does concurrent carotid endarterectomy with coronary artery bypass grafting improve outcomes in patients with dual arterial disease? A systematic review and meta-analysis of randomised controlled trials and propensity-matched studies

Kristine Santos* ORCID logo, Giovanna Macanhã Scremin, Neel Patel, Amal Zakani, Mihaela Mariș, Tomasz Plonek
*Corresponding Author: Email: santos.kristine13@yahoo.co.uk

Abstract

Patients with coexisting carotid and coronary artery disease face a complex surgical decision regarding whether to undergo coronary artery bypass grafting (CABG) alone or combined with carotid endarterectomy (CEA). Evidence remains conflicting, with some studies suggesting stroke reduction from a combined approach while others report increased perioperative morbidity without a survival advantage, contributing to weak ACCF/AHA and ESC/EACTS guideline recommendations. We conducted a systematic review and meta-analysis of randomised controlled trials and propensity-matched studies comparing CABG alone versus CABG+CEA. Five studies involving 23,916 patients were included, of whom 29% underwent combined surgery. CABG+CEA was associated with a significantly higher incidence of perioperative stroke (OR 1.5; 95% CI 1.1–2.0; p=0.03), but no significant differences were observed in 30-day mortality, major adverse cardiovascular events, myocardial infarction, or hospital length of stay. These findings indicate that adding CEA to CABG increases stroke risk without providing a clear survival benefit, supporting guideline recommendations for a selective, risk-based strategy. Until higher-quality evidence becomes available, concurrent CEA+CABG should be reserved for carefully selected patients in whom the anticipated benefits outweigh potential harms.
First Name
Last Name
Email Address
Comments
Security code


Abstract View: 0

Your browser does not support the canvas element.

PDF Download: 0

Your browser does not support the canvas element.